James M. Hussey has been appointed president of Sagent Pharmaceuticals. Mr. Hussey will be responsible for commercial operations, including development, regulatory and supply chain activities, as well as having primary responsibility for the company’s sales, marketing and human resources functions.   Mr. Hussey has more than 25 years of experience in the pharmaceutical and healthcare industries. Most recently he served as chief executive officer of NanoInk, a privately held nanolithography compa...